1. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

   • B. A. Johnson
   • N. Ait-Daoud

   Review Pages: 327 - 344

2. Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice

   • I. A. Sukhotina
   • A. Y. Bespalov

   Original Investigation Pages: 345 - 350

3. Comparison of the neurophysiological effects of allopregnanolone and ethanol in rats

   • C. J. Slawecki
   • T. Walpole
   • C. L. Ehlers

   Original Investigation Pages: 351 - 359

4. Sleep changes during long-term treatment of depression with fluvoxamine – a home-based study

   • S. J. Wilson
   • C. Bell
   • D. J. Nutt

   Original Investigation Pages: 360 - 365

5. Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat

   • L. M. Broersen
   • F. Abbate
   • B. Olivier

   Original Investigation Pages: 366 - 376

6. In vivo estimates of efficacy at 5-HT_1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats

   • W. Koek
   • M.-B. Assié
   • C. P. France

   Original Investigation Pages: 377 - 387

7. Effects of methyllycaconitine (MLA), an α₇ nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward

   • G. Panagis
   • A. Kastellakis
   • G. Nomikos

   Original Investigation Pages: 388 - 396

8. Socio-psychological stress-induced antinociception in diabetic mice

   • J. Kamei
   • M. Ohsawa

   Original Investigation Pages: 397 - 400

9. Acquisition of oral phencyclidine self-administration in rhesus monkeys: effect of sex

   • M. E. Carroll
   • M. E. Roth
   • P. D. Nguyen

   Original Investigation Pages: 401 - 408

10. The P300 brain potential is reduced in smokers

    • A. P. Anokhin
    • A. B. Vedeniapin
    • J. W. Rohrbaugh

    Original Investigation Pages: 409 - 413